Prevalence of preeclampsia and associated factors among pregnant women delivering in Vietnam: a cross-sectional study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20260164Keywords:
Preeclampsia, Vietnam, Prevalence, Risk factorsAbstract
Background: Preeclampsia is a leading cause of maternal and fetal mortality and morbidity globally. This study aims to determine the prevalence of preeclampsia and identify associated factors among pregnant women presenting for delivery in Ho Chi Minh City, Vietnam.
Methods: A cross-sectional descriptive study was conducted on 386 pregnant women with a gestational age greater than 20 weeks presenting for delivery in Ho Chi Minh City, Vietnam. Data were collected via direct interviews and medical record reviews. Variables were analyzed using Chi-square and Fisher's exact tests.
Results: The prevalence of preeclampsia in the study group was 2.59% (10/386). Factors showing a statistically significant association (p < 0.05) with preeclampsia included: place of residence (non-urban areas had a higher risk), religion, mode of previous delivery, history of preterm birth, and history of miscarriage. No statistically significant association was found between preeclampsia and age group, occupation, education level, body mass index (BMI), smoking/alcohol habits, or family history.
Conclusions: The prevalence of preeclampsia among pregnant women delivering in Ho Chi Minh City is 2.59%. Identifying associated factors, such as adverse obstetric history and geographical factors, is essential to improve screening and pregnancy management.
Metrics
References
Yi J, Chen L, Meng X, Chen Y. Risk factors and foetal growth restriction associated with expectant treatment of early-onset preeclampsia. Ann Med. 2022;54(1):3249-56. DOI: https://doi.org/10.1080/07853890.2022.2144642
Haile TG, Assefa N, Alemayehu T, Mariye T, Geberemeskel GG, Bahrey D et al. Determinants of preeclampsia among women attending delivery services in public hospitals of central Tigray, northern Ethiopia: a case-control study. J Pregn. 2021;2021:1-8. DOI: https://doi.org/10.1155/2021/4654828
Lisonkova S, Bone JN, Muraca GM, Razaz N, Wang LQ, Sabr Y, et al. Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study. Am J Obstet Gynecol. 2021;225(5):538.e1-538.e19. DOI: https://doi.org/10.1016/j.ajog.2021.04.261
Cui J, Yang Z, Ma R, He W, Tao H, Li Y et al. Placenta-targeted treatment strategies for preeclampsia and fetal growth restriction: an opportunity and major challenge. Stem Cell Rev Rep. 2024;20(6):1501-11. DOI: https://doi.org/10.1007/s12015-024-10739-x
Parada-Niño L, Castillo-León LF, Morel A. Preeclampsia, natural history, genes, and miRNAs associated with the syndrome. J Pregn. 2022;2022(1):1-12. DOI: https://doi.org/10.1155/2022/3851225
Allard M, Grosch S, Jouret F, Masson V, Surinder T, Masset C. [Prevention of preeclampsia and its complications]. Rev Med Liege. 2024;79(5-6):448-54.
Srialluri N, Surapaneni A, Chang A, Mackeen AD, Paglia MJ, Grams ME. Preeclampsia and long-term kidney outcomes: an observational cohort study. Am J Kidney Dis. 2023;82(6):698-705. DOI: https://doi.org/10.1053/j.ajkd.2023.04.010
Chang K-J, Seow K-M, Chen K-H. Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition. Int J Environ Res Publ Heal. 2023;20(4):2994. DOI: https://doi.org/10.3390/ijerph20042994
Chai L, Li S, Yin B, Zhu X, Zhu B, Wu K. Prevalence, risk factors, and adverse perinatal outcomes in Chinese women with preeclampsia: a large retrospective cohort study. J Health Popul Nutr. 2025;44(1):32. DOI: https://doi.org/10.1186/s41043-025-00778-6
Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and China. JAMA Netw Open. 2021;4(5):e218401. DOI: https://doi.org/10.1001/jamanetworkopen.2021.8401
Ayele AD, Tilahun ZA. Magnitude of preeclampsia and associated factors among women attending delivery service in Debre Tabor Specialized Hospital. Ethiop J Heal Sci. 2022;32(2). DOI: https://doi.org/10.4314/ejhs.v32i2.8
Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Das Trisha A, et al. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021;11(1):21339. DOI: https://doi.org/10.1038/s41598-021-00839-w
Farina A, Cavoretto PI, Syngelaki A, Morano D, Adjahou S, Nicolaides KH. The 36-week preeclampsia risk by the Fetal Medicine Foundation algorithm is associated with fetal compromise following induction of labor. Am J Obstet Gynecol. 2025;233(1):57.e1-57.e12. DOI: https://doi.org/10.1016/j.ajog.2024.12.025
Gunderson EP, Greenberg M, Najem M, Sun B, Alexeeff SE, Alexander J, et al. Severe maternal morbidity associated with chronic hypertension, preeclampsia, and gestational hypertension. JAMA Netw Open. 2025;8(1):e2451406. DOI: https://doi.org/10.1001/jamanetworkopen.2024.51406
Osman T, Keshk EA, Alghamdi AA, Alghamdi MA, Alghamdi MA, Alzahrani AA, et al. Awareness of Preeclampsia and Its Associated Factors Among Women in Al Baha Region, Saudi Arabia. Cureus. 2023;15(11). DOI: https://doi.org/10.7759/cureus.49038
Mekie M, Addisu D, Bezie M, Melkie A, Getaneh D, Bayih WA, et al. Knowledge and attitude of pregnant women towards preeclampsia and its associated factors in South Gondar Zone, Northwest Ethiopia: a multi‐center facility‐based cross‐sectional study. BMC Pregn Childbirth. 2021;21:160. DOI: https://doi.org/10.1186/s12884-021-03647-2
Korkes HA, Cavalli RC, Oliveira LGD, Ramos JGL, Martins Costa SHDA, Sousa FLPD, et al. How can we reduce maternal mortality due to preeclampsia? The 4P rule. Rev Bras Ginecol E Obstetrícia. 2024;46:e-rbgo43. DOI: https://doi.org/10.61622/rbgo/2024rbgo43
Schuurmans J, Borgundvaag E, Finaldi P, Senat-Delva R, Desauguste F, Badjo C, et al. Risk factors for adverse outcomes in women with high-risk pregnancy and their neonates, Haiti. Revista Panamericana de Salud Públ. 2021;45:e147. DOI: https://doi.org/10.26633/RPSP.2021.147
Amar S, Potter BJ, Paradis G, Lewin A, Maniraho A, Brousseau É, et al. Outcomes of Postpartum Preeclampsia: A Retrospective Cohort Study of 1.3 Million Pregnancies. BJOG Int J Obstet Gynaecol. 2025;132(6):752-9. DOI: https://doi.org/10.1111/1471-0528.18030
Fondjo LA, Amoah B, Tashie W, Annan JJ. Risk factors for the development of new-onset and persistent postpartum preeclampsia: A case-control study in Ghana. Womens Health. 2022;18:17455057221109362. DOI: https://doi.org/10.1177/17455057221109362
Nakimuli A, Jasper BA, Nakubulwa S, Adroma M, Akello J, Namagembe I, et al. Risk factors associated with progression from pre‐eclampsia to eclampsia: A prospective cohort study and population‐wide data analysis. Acta Obstet Gynecol Scand. 2025;104:1487-95. DOI: https://doi.org/10.1111/aogs.15154
Downloads
Published
How to Cite
Issue
Section
